Aduro Biotech

$1.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (4.65%) Today
-$0.04 (-2.96%) As of 4:01 PM EDT after-hours

Why Robinhood?

You can buy or sell Aduro Biotech and other stocks, options, ETFs, and crypto commission-free!

About ADRO

Aduro Biotech, Inc. Common Stock, also called Aduro Biotech, is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Read More Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.

Employees
152
Headquarters
Berkeley, California
Founded
2000
Market Cap
103.38M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
356.99K
High Today
$1.35
Low Today
$1.27
Open Price
$1.28
Volume
216.57K
52 Week High
$7.64
52 Week Low
$1.15

Collections

ADRO Earnings

-$0.36
-$0.30
-$0.25
-$0.19
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 30, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.